JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis.

PLoS One · 2013 · PMC3608564 · PMID 23555782

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

Finally, change in JAK2 V617F genotype during follow-up was associated with an increased risk of BT, which however did not reach statistical significance (HR 2.45, 95% CI, 0.89–6.71; P = 0.08) in a bivariable analysis including JAK2 V617F status at diagnosis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.